These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
90 related articles for article (PubMed ID: 2573987)
21. Treatment of early Parkinson's disease with controlled-release levodopa preparations. Rinne UK; Rinne JO Neurology; 1989 Nov; 39(11 Suppl 2):78-81; discussion 95. PubMed ID: 2586766 [TBL] [Abstract][Full Text] [Related]
25. Long-term treatment with levodopa in a family with autosomal dominant torsion dystonia. de Yebenes JG; Moskowitz C; Fahn S; Saint-Hilaire MH Adv Neurol; 1988; 50():101-11. PubMed ID: 3400489 [No Abstract] [Full Text] [Related]
26. [Treatment and prognosis of the therapeutic effect of L-DOPA in dystonia musculorum deformans]. Mel'nichuk PV; Minich LN Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(8):1002-6. PubMed ID: 484133 [TBL] [Abstract][Full Text] [Related]
27. Dopa responsive dystonia in a girl with vitiligo. Chaudhary N; Mani J; Rawat S; Mulye R; Shah P Indian Pediatr; 1998 Jul; 35(7):663-5. PubMed ID: 10216678 [No Abstract] [Full Text] [Related]
28. Tyrosine hydroxylase deficiency causes progressive encephalopathy and dopa-nonresponsive dystonia. Hoffmann GF; Assmann B; Bräutigam C; Dionisi-Vici C; Häussler M; de Klerk JB; Naumann M; Steenbergen-Spanjers GC; Strassburg HM; Wevers RA Ann Neurol; 2003; 54 Suppl 6():S56-65. PubMed ID: 12891655 [TBL] [Abstract][Full Text] [Related]
30. Pharmacokinetics and bioavailability of Sinemet CR: a summary of human studies. Yeh KC; August TF; Bush DF; Lasseter KC; Musson DG; Schwartz S; Smith ME; Titus DC Neurology; 1989 Nov; 39(11 Suppl 2):25-38. PubMed ID: 2685649 [TBL] [Abstract][Full Text] [Related]
31. A controlled trial of levodopa plus carbidopa in the treatment of winter seasonal affective disorder: a test of the dopamine hypothesis. Oren DA; Moul DE; Schwartz PJ; Wehr TA; Rosenthal NE J Clin Psychopharmacol; 1994 Jun; 14(3):196-200. PubMed ID: 8027416 [TBL] [Abstract][Full Text] [Related]
33. [Characteristics of the clinical course, pathogenesis and treatment of torsion dystonia in childhood]. Markova ED Zh Nevropatol Psikhiatr Im S S Korsakova; 1989; 89(8):32-5. PubMed ID: 2588895 [TBL] [Abstract][Full Text] [Related]
36. Antiparkinsonian activity of a single oral dose of PHNO. Grandas F; Quinn N; Critchley P; Rohan A; Marsden CD; Stahl SM Mov Disord; 1987; 2(1):47-51. PubMed ID: 2904120 [TBL] [Abstract][Full Text] [Related]
37. [Usefulness of increasing the proportion of carbidopa to levodopa in the long-term treatment of Parkinson's disease]. Bermejo Pareja F; Martínez-Martín P Med Clin (Barc); 1984 Feb; 82(7):305-10. PubMed ID: 6717135 [No Abstract] [Full Text] [Related]
38. [The differentiated treatment of dystonia musculorum deformans in children]. Mal'mberg SA Zh Nevrol Psikhiatr Im S S Korsakova; 1993; 93(5):33-6. PubMed ID: 7908772 [TBL] [Abstract][Full Text] [Related]
40. Controlled-release carbidopa-levodopa (Sinemet) in combination with standard Sinemet in advanced Parkinson's disease. Mark MH; Sage JI Ann Clin Lab Sci; 1989; 19(2):101-6. PubMed ID: 2665626 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]